{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:13:54Z","timestamp":1782454434342,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1038\/s41409-022-01797-1","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T11:25:53Z","timestamp":1662377153000},"page":"1751-1757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20\u2013a very high-risk subtype in B-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"57","author":[{"given":"Bingqing","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dainan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-0883","authenticated-orcid":false,"given":"Ren","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4015-3952","authenticated-orcid":false,"given":"Qifa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-5856","authenticated-orcid":false,"given":"Hongsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"1797_CR1","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1002\/ijc.32799","volume":"146","author":"J Zinngrebe","year":"2020","unstructured":"Zinngrebe J, Schlichtig F, Kraus JM, Meyer M, Boldrin E, Kestler HA, et al. Biomarker profile for prediction of response to SMAC mimetic monotherapy in pediatric precursor B-cell acute lymphoblastic leukemia. Int J Cancer. 2020;146:3219\u201331. https:\/\/doi.org\/10.1002\/ijc.32799.","journal-title":"Int J Cancer"},{"key":"1797_CR2","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","volume":"120","author":"CH Pui","year":"2012","unstructured":"Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there. Blood. 2012;120:1165\u201374. https:\/\/doi.org\/10.1182\/blood-2012-05-378943.","journal-title":"Blood"},{"key":"1797_CR3","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","volume":"133","author":"W Stock","year":"2019","unstructured":"Stock W, Luger SM, Advani AS, Yin J, Harvey RC, Mullighan CG, et al. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. Blood. 2019;133:1548\u201359. https:\/\/doi.org\/10.1182\/blood-2018-10-881961.","journal-title":"Blood"},{"key":"1797_CR4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3324\/haematol.2019.220756","volume":"105","author":"A Lazaryan","year":"2020","unstructured":"Lazaryan A, Dolan M, Zhang MJ, Wang HL, Kharfan-Dabaja MA, Marks DI, et al. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica. 2020;105:1329\u201338. https:\/\/doi.org\/10.3324\/haematol.2019.220756.","journal-title":"Haematologica"},{"key":"1797_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/BLCTT.S245210","volume":"11","author":"C Bender","year":"2021","unstructured":"Bender C, Maese L, Carter-Febres M, Verma A. Clinical utility of pegaspargase in children, adolescents and young adult patients with acute lymphoblastic leukemia: a review. Blood Lymphat Cancer. 2021;11:25\u201340. https:\/\/doi.org\/10.2147\/BLCTT.S245210.","journal-title":"Blood Lymphat Cancer"},{"key":"1797_CR6","doi-asserted-by":"publisher","unstructured":"Bassan R, Bourquin JP, DeAngelo DJ, Chiaretti S. New approaches to the management of adult acute lymphoblastic leukemia. J Clin Oncol. 2018:JCO2017773648. https:\/\/doi.org\/10.1200\/JCO.2017.77.3648","DOI":"10.1200\/JCO.2017.77.3648"},{"key":"1797_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature06866","volume":"453","author":"CG Mullighan","year":"2008","unstructured":"Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008;453:110\u20134. https:\/\/doi.org\/10.1038\/nature06866.","journal-title":"Nature"},{"key":"1797_CR8","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3109\/10428194.2016.1144881","volume":"57","author":"R DeBoer","year":"2016","unstructured":"DeBoer R, Koval G, Mulkey F, Wetzler M, Devine S, Marcucci G, et al. Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Leuk Lymphoma. 2016;57:2298\u2013306. https:\/\/doi.org\/10.3109\/10428194.2016.1144881.","journal-title":"Leuk Lymphoma"},{"key":"1797_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1182\/blood-2012-08-450114","volume":"121","author":"I Ferreiros-Vidal","year":"2013","unstructured":"Ferreiros-Vidal I, Carroll T, Taylor B, Terry A, Liang Z, Bruno L, et al. Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation. Blood. 2013;121:1769\u201382. https:\/\/doi.org\/10.1182\/blood-2012-08-450114.","journal-title":"Blood"},{"key":"1797_CR10","doi-asserted-by":"publisher","first-page":"100677","DOI":"10.1016\/j.blre.2020.100677","volume":"44","author":"S Vairy","year":"2020","unstructured":"Vairy S, Tran TH. IKZF1 alterations in acute lymphoblastic leukemia: the good, the bad and the ugly. Blood Rev. 2020;44:100677 https:\/\/doi.org\/10.1016\/j.blre.2020.100677.","journal-title":"Blood Rev"},{"key":"1797_CR11","doi-asserted-by":"publisher","first-page":"106683","DOI":"10.1016\/j.leukres.2021.106683","volume":"111","author":"SK Gupta","year":"2021","unstructured":"Gupta SK, Bakhshi S, Kamal VK, Gupta R, Sharma P, Pushpam D, et al. Proposal and clinical application of molecular genetic risk scoring system, \u201cMRplus\u201d, for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre. Leuk Res. 2021;111:106683 https:\/\/doi.org\/10.1016\/j.leukres.2021.106683.","journal-title":"Leuk Res"},{"key":"1797_CR12","doi-asserted-by":"publisher","unstructured":"Felice MS, Rubio PL, Digiorge J, Barreda Frank M, Martinez CS, Guitter MR et al. Impact of IKZF1 Deletions in the Prognosis of Childhood Acute Lymphoblastic Leukemia in Argentina. Cancers (Basel). 2022;14. https:\/\/doi.org\/10.3390\/cancers14133283.","DOI":"10.3390\/cancers14133283"},{"key":"1797_CR13","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1200\/JCO.2017.74.3617","volume":"36","author":"M Stanulla","year":"2018","unstructured":"Stanulla M, Dagdan E, Zaliova M, Moricke A, Palmi C, Cazzaniga G, et al. IKZF1(plus) defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric B-cell precursor acute lymphoblastic leukemia. J Clin Oncol. 2018;36:1240\u20139. https:\/\/doi.org\/10.1200\/JCO.2017.74.3617.","journal-title":"J Clin Oncol"},{"key":"1797_CR14","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/jamaoncol.2018.1915","volume":"4","author":"E Jabbour","year":"2018","unstructured":"Jabbour E, Pui CH, Kantarjian H. Progress and innovations in the management of adult acute lymphoblastic leukemia. JAMA Oncol. 2018;4:1413\u201320. https:\/\/doi.org\/10.1001\/jamaoncol.2018.1915.","journal-title":"JAMA Oncol"},{"key":"1797_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N. Engl J Med. 2014;371:1005\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1403088.","journal-title":"N. Engl J Med"},{"key":"1797_CR16","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1182\/blood-2008-04-151860","volume":"113","author":"DA Thomas","year":"2009","unstructured":"Thomas DA, O\u2019Brien S, Jorgensen JL, Cortes J, Faderl S, Garcia-Manero G, et al. Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia. Blood. 2009;113:6330\u20137. https:\/\/doi.org\/10.1182\/blood-2008-04-151860.","journal-title":"Blood"},{"key":"1797_CR17","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/leu.2012.122","volume":"26","author":"T Kalina","year":"2012","unstructured":"Kalina T, Flores-Montero J, van der Velden VH, Martin-Ayuso M, Bottcher S, Ritgen M, et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia. 2012;26:1986\u20132010. https:\/\/doi.org\/10.1038\/leu.2012.122.","journal-title":"Leukemia"},{"key":"1797_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3324\/haematol.2012.073965","volume":"98","author":"A Caye","year":"2013","unstructured":"Caye A, Beldjord K, Mass-Malo K, Drunat S, Soulier J, Gandemer V, et al. Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia. Haematologica. 2013;98:597\u2013601. https:\/\/doi.org\/10.3324\/haematol.2012.073965.","journal-title":"Haematologica"},{"key":"1797_CR19","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.bbmt.2009.06.017","volume":"15","author":"QF Liu","year":"2009","unstructured":"Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, et al. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Biol Blood Marrow Transpl. 2009;15:1376\u201385. https:\/\/doi.org\/10.1016\/j.bbmt.2009.06.017.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1797_CR20","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1182\/blood.2020007311","volume":"137","author":"JM Ribera","year":"2021","unstructured":"Ribera JM, Morgades M, Ciudad J, Montesinos P, Esteve J, Genesca E, et al. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia. Blood. 2021;137:1879\u201394. https:\/\/doi.org\/10.1182\/blood.2020007311.","journal-title":"Blood"},{"key":"1797_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13045-017-0503-2","volume":"10","author":"Q Fan","year":"2017","unstructured":"Fan Q, Liu H, Liang X, Yang T, Fan Z, Huang F, et al. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia. J Hematol Oncol. 2017;10:135 https:\/\/doi.org\/10.1186\/s13045-017-0503-2.","journal-title":"J Hematol Oncol"},{"key":"1797_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7:e577 https:\/\/doi.org\/10.1038\/bcj.2017.53.","journal-title":"Blood Cancer J"},{"key":"1797_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13045-019-0703-z","volume":"12","author":"D Liu","year":"2019","unstructured":"Liu D, Zhao J, Song Y, Luo X, Yang T. Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia. J Hematol Oncol. 2019;12:15 https:\/\/doi.org\/10.1186\/s13045-019-0703-z.","journal-title":"J Hematol Oncol"},{"key":"1797_CR24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/bjh.13514","volume":"170","author":"L Olsson","year":"2015","unstructured":"Olsson L, Ivanov Ofverholm I, Noren-Nystrom U, Zachariadis V, Nordlund J, Sjogren H, et al. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013. Br J Haematol. 2015;170:847\u201358. https:\/\/doi.org\/10.1111\/bjh.13514.","journal-title":"Br J Haematol"},{"key":"1797_CR25","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1182\/blood.2019002655","volume":"136","author":"C Song","year":"2020","unstructured":"Song C, Ge Z, Ding Y, Tan BH, Desai D, Gowda K, et al. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia. Blood. 2020;136:1520\u201334. https:\/\/doi.org\/10.1182\/blood.2019002655.","journal-title":"Blood"},{"key":"1797_CR26","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/leu.2015.359","volume":"30","author":"R Marke","year":"2016","unstructured":"Marke R, Havinga J, Cloos J, Demkes M, Poelmans G, Yuniati L, et al. Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia. Leukemia. 2016;30:1599\u2013603. https:\/\/doi.org\/10.1038\/leu.2015.359.","journal-title":"Leukemia"},{"key":"1797_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature21076","volume":"542","author":"LN Chan","year":"2017","unstructured":"Chan LN, Chen Z, Braas D, Lee JW, Xiao G, Geng H, et al. Metabolic gatekeeper function of B-lymphoid transcription factors. Nature. 2017;542:479\u201383. https:\/\/doi.org\/10.1038\/nature21076. e-pub ahead of print 2017\/02\/14","journal-title":"Nature"},{"key":"1797_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ccell.2015.07.016","volume":"28","author":"ML Churchman","year":"2015","unstructured":"Churchman ML, Low J, Qu C, Paietta EM, Kasper LH, Chang Y, et al. Efficacy of retinoids in IKZF1-mutated BCR-ABL1 acute lymphoblastic leukemia. Cancer Cell. 2015;28:343\u201356. https:\/\/doi.org\/10.1016\/j.ccell.2015.07.016.","journal-title":"Cancer Cell"},{"key":"1797_CR29","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1056\/NEJMoa2016272","volume":"383","author":"R Foa","year":"2020","unstructured":"Foa R, Bassan R, Vitale A, Elia L, Piciocchi A, Puzzolo MC, et al. Dasatinib-blinatumomab for Ph-positive acute lymphoblastic leukemia in adults. N Engl J Med. 2020;383:1613\u201323. https:\/\/doi.org\/10.1056\/NEJMoa2016272.","journal-title":"N Engl J Med"},{"key":"1797_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41409-018-0249-7","volume":"54","author":"S Tang","year":"2019","unstructured":"Tang S, Shen H, Qu C, Dai H, Zhu X, Xue S, et al. Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes. Bone Marrow Transpl. 2019;54:236\u201343. https:\/\/doi.org\/10.1038\/s41409-018-0249-7.","journal-title":"Bone Marrow Transpl"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01797-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01797-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01797-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T12:59:41Z","timestamp":1669899581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01797-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1797"],"URL":"https:\/\/doi.org\/10.1038\/s41409-022-01797-1","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"26 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was performed in accordance with the Declaration of Helsinki, and the protocol was approved by\u00a0ethical review boards of\u00a0Southern Hospital, Southern Medical University before study initiation(NFEC-2018-002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}